Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Chronic Heart Failure

Free Subscription 27.03.2023 4 Am Heart J 1 Am J Cardiol 1 Basic Res Cardiol 3 Cardiovasc Res 1 Circ Cardiovasc Interv 2 Circ Heart Fail 1 Circ Res 1 Circulation 2 Clin Cardiol 4 Eur Heart J 1 Heart 1 Hypertension 5 Int J Cardiol 3 J Am Coll Cardiol 8 J Card Fail 1 J Mol Cell Cardiol 1 Lancet 1 N Engl J Med 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. FU G, Zhou Z, Jian B, Huang S, et al
   Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
   Am Heart J. 2023;258:177-185.
   PubMed         Abstract available
   
   
2. SILVAIN J, Cayla G, Ferrari E, Range G, et al
   betaeta Blocker Interruption after Uncomplicated Myocardial Infarction: Rationale and Design of the randomized ABYSS trial.
   Am Heart J. 2023 Jan 19:S0002-8703(23)00021-2. doi: 10.1016/j.ahj.2023.
   PubMed         Abstract available
   
   
3. JOHNSON M, Morrison FJ, McMahon G, Su M, et al
   Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.
   Am Heart J. 2023;258:49-59.
   PubMed         Abstract available
   
   
4. MUKHOPADHYAY A, Reynolds HR, Xia Y, Phillips LM, et al
   Design and pilot implementation for the BETTER CARE-HF trial: A pragmatic cluster-randomized controlled trial comparing two targeted approaches to ambulatory clinical decision support for cardiologists.
   Am Heart J. 2023;258:38-48.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

5. GOYAL A, Dalia T, Ranka S, Sauer AJ, et al
   Impact of Biopsy Proven Liver Fibrosis on Patients Undergoing Evaluation and Treatment for Advanced Heart Failure Surgical Therapies.
   Am J Cardiol. 2023;194:46-55.
   PubMed         Abstract available
   
   

   
   Basic Res Cardiol

6. OEING CU, Pepin ME, Saul KB, Agircan AS, et al
   Indirect epigenetic testing identifies a diagnostic signature of cardiomyocyte DNA methylation in heart failure.
   Basic Res Cardiol. 2023;118:9.
   PubMed         Abstract available
   
   

   
   Cardiovasc Res

7. FAYYAZ AU, Sabbah MS, Dasari S, Griffiths LG, et al
   Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension.
   Cardiovasc Res. 2023;119:268-282.
   PubMed         Abstract available
   
   
8. PARKSOOK WW, Williams GH
   Aldosterone and cardiovascular diseases.
   Cardiovasc Res. 2023;119:28-44.
   PubMed         Abstract available
   
   
9. SAMUELSSON AM, Bartolomaeus TUP, Anandakumar H, Thowsen I, et al
   VEGF-B hypertrophy predisposes to transition from diastolic to systolic heart failure in hypertensive rats.
   Cardiovasc Res. 2023 Mar 23:cvad040. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Interv

10. HONG D, Shin D, Lee SH, Joh HS, et al
    Prognostic Impact of Coronary Microvascular Dysfunction According to Different Patterns by Invasive Physiologic Indexes in Symptomatic Patients With Intermediate Coronary Stenosis.
    Circ Cardiovasc Interv. 2023 Feb 27:e012621.
    PubMed         Abstract available
    
    

    
    Circ Heart Fail

11. MARTENS P, Bhattacharya S, Longinow J, Ives L, et al
    Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis.
    Circ Heart Fail. 2023 Jan 25:e010078. doi: 10.1161/CIRCHEARTFAILURE.122.010078.
    PubMed         Abstract available
    
    
12. BUTT JH, Ibrahim W, Dewan P, Desai AS, et al
    Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial.
    Circ Heart Fail. 2023;16:e010111.
    PubMed         Abstract available
    
    

    
    Circ Res

13. YE S, Huang H, Han X, Luo W, et al
    Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling.
    Circ Res. 2023;132:707-722.
    PubMed         Abstract available
    
    

    
    Circulation

14. SACHDEV V, Sharma K, Keteyian SJ, Alcain CF, et al
    Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2023 Mar 21. doi: 10.1161/CIR.0000000000001122.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

15. ZHANG W, Chen L, Zhou X, Huang J, et al
    Resynchronization effects and clinical outcomes during left bundle branch area pacing with and without conduction system capture.
    Clin Cardiol. 2023;46:287-295.
    PubMed         Abstract available
    
    
16. SHIMODA T, Imanishi R, Kou N, Okamura Y, et al
    Influence of antidiabetic medications on predictive aptitude of TyG index for HFpEF.
    Clin Cardiol. 2023;46:345.
    PubMed        
    
    

    
    Eur Heart J

17. SATO R, von Haehling S
    Revisiting the obesity paradox in heart failure: what is the best anthropometric index to gauge obesity?
    Eur Heart J. 2023 Mar 22:ehad079. doi: 10.1093.
    PubMed        
    
    
18. BUTT JH, Petrie MC, Jhund PS, Sattar N, et al
    Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.
    Eur Heart J. 2023 Mar 22:ehad083. doi: 10.1093.
    PubMed         Abstract available
    
    
19. PACKER M, Siddiqi TJ, Butler J
    Drugs that slow the progression of diabetic kidney disease: are renoprotective effects attenuated in heart failure?
    Eur Heart J. 2023 Mar 21:ehad158. doi: 10.1093.
    PubMed        
    
    
20. LIUZZO G, Volpe M
    TRANSFORM-HF closes the loop on diuretic therapy in heart failure.
    Eur Heart J. 2023 Mar 21:ehad124. doi: 10.1093.
    PubMed        
    
    

    
    Heart

21. JASINSKA-PIADLO A, Campbell P
    Management of patients with heart failure and preserved ejection fraction.
    Heart. 2023 Mar 22:heartjnl-2022-321097. doi: 10.1136/heartjnl-2022-321097.
    PubMed        
    
    

    
    Hypertension

22. SIDDIQUI M, Hannon L, Wang Z, Blair J, et al
    Hypertension and Cardiovascular Disease Risk Among Individuals With Versus Without HIV.
    Hypertension. 2023 Jan 25. doi: 10.1161/HYPERTENSIONAHA.122.19889.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

23. HORTEGAL RA, Valeri R, Grizante M, Cancellier R, et al
    Afterload increase challenge unmasks systolic abnormalities in heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Mar 21:S0167-5273(23)00453.
    PubMed         Abstract available
    
    
24. FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
    Prevalence and prognostic impact of the coexistence of cachexia and sarcopenia in older patients with heart failure.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00447.
    PubMed         Abstract available
    
    
25. TAKIMURA H, Taniguchi R, Tsuzuki I, Tajima E, et al
    Impact of the time-to-target rate of urine volume concept on the outcome of acute decompensated heart failure.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00445.
    PubMed         Abstract available
    
    
26. KUMAR HU, Nearing BD, Mittal S, Premchand RK, et al
    Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction: ANTHEM-HFpEF study results.
    Int J Cardiol. 2023 Mar 17:S0167-5273(23)00440.
    PubMed         Abstract available
    
    
27. KOH SJQ, Yap J, Jiang Y, Sng GGR, et al
    Clinical outcomes in end stage renal disease on dialysis and severe coronary artery disease: A real-world study.
    Int J Cardiol. 2023;378:105-110.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

28. SACHDEV V, Sharma K, Keteyian SJ, Alcain CF, et al
    Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology.
    J Am Coll Cardiol. 2023 Mar 14:S0735-1097(23)00368.
    PubMed         Abstract available
    
    
29. DOMANSKI MJ, Wu CO, Tian X, Hasan AA, et al
    Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk Factors.
    J Am Coll Cardiol. 2023;81:1151-1161.
    PubMed         Abstract available
    
    
30. LYNCH A, Tatangelo M, Ahuja S, Steve Fan CP, et al
    Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2023;81:1035-1045.
    PubMed         Abstract available
    
    

    
    J Card Fail

31. LE JN, Zhou R, Tao R, Dharmavaram N, et al
    Recumbent Ergometer vs Treadmill Cardiopulmonary Exercise Test in HFpEF: Implications for Chronotropic Response and Exercise Capacity.
    J Card Fail. 2023;29:407-413.
    PubMed         Abstract available
    
    
32. ALEKSOVA N, Buchan TA, Foroutan F, Zhu A, et al
    Extracorporeal Membrane Oxygenation for Graft Dysfunction Early After Heart Transplantation: A Systematic Review and Meta-analysis.
    J Card Fail. 2023;29:290-303.
    PubMed         Abstract available
    
    
33. CLARK KAA, Morris AA
    Moving Toward "Precision" Medicine: Can We Tailor Diabetes Therapy to Patients' Differential Risks of Future Cardiovascular Disease?
    J Card Fail. 2023;29:255-257.
    PubMed        
    
    
34. HOWIE-ESQUIVEL J, Metzger M, Malin SK, Mazimba S, et al
    Getting into Light Exercise (GENTLE-HF) for Patients with Heart Failure: The Design and Methodology of a Live-Video Group Exercise Study.
    J Card Fail. 2023 Mar 20:S1071-9164(23)00079.
    PubMed         Abstract available
    
    
35. CARROLL AM, Farr M, Russell SD, Schlendorf KH, et al
    Beyond Stage C: Considerations in the Management of Patients with Heart Failure Progression and Gaps in Evidence.
    J Card Fail. 2023 Mar 21:S1071-9164(23)00078.
    PubMed         Abstract available
    
    
36. HAMID N, Jorde UP, Reisman M, Latib A, et al
    Transcatheter Left Ventricular Restoration in patients with Heart Failure.
    J Card Fail. 2023 Mar 21:S1071-9164(23)00070.
    PubMed         Abstract available
    
    
37. BIDWELL JT, Conway C, Babicheva V, Lee CS, et al
    Person with Heart Failure and Care Partner Dyads: Current Knowledge, Challenges, and Future Directions: State-of-the-Art Review.
    J Card Fail. 2023 Mar 21:S1071-9164(23)00075.
    PubMed         Abstract available
    
    
38. KECK C, Gregoski M, Litwin S, Borlaug BA, et al
    Decoupling of Hemodynamics and Congestive Symptoms in Obese Heart Failure Patients.
    J Card Fail. 2023 Mar 22:S1071-9164(23)00077.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

39. FUJII S, Kobayashi S, Chang Y, Nawata J, et al
    RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
    J Mol Cell Cardiol. 2023 Mar 22:S0022-2828(23)00052.
    PubMed         Abstract available
    
    

    
    Lancet

40. HE J, Ouyang N, Guo X, Sun G, et al
    Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial.
    Lancet. 2023 Mar 2:S0140-6736(22)02603-4. doi: 10.1016/S0140-6736(22)02603.
    PubMed         Abstract available
    
    

    
    N Engl J Med

41. HOUSTON BA, Brittain EL, Tedford RJ
    Right Ventricular Failure.
    N Engl J Med. 2023;388:1111-1125.
    PubMed        
    
    

    
    PLoS One

42. MULUGETA H, Sinclair PM, Wilson A
    Prevalence of depression and its association with health-related quality of life in people with heart failure in low- and middle-income countries: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0283146.
    PubMed         Abstract available
    
    
43. BERGMARK RW, Jin G, Semco RS, Santolini M, et al
    Association of hospital centrality in inter-hospital patient-sharing networks with patient mortality and length of stay.
    PLoS One. 2023;18:e0281871.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: